Caroline Foundation Clinical Trials Begin

The Caroline Foundation have just announced the beginnings of their first clinical trial for patients with first-line HER2+ MBC.

Which, we reckon, is damn good news. Even if we haven’t a clue that first-line HER2+ MBC means.

Over to Dermod and the gang…

What wonderful news to announce – the Caroline 1 Trial for patients with first-line HER2+ MBC will be initiated January 6th 2020. We are so proud to support the work of Professor John Crown and that of our dedicated researchers Denis Collins, National Institute for Cellular Biotechnology DCU, Dr Nicola Gaynor, & those whose work has led to this trial by Dr Norma O’Donovan & Cancer Clinical Research Trust. May this trial lead to new insights & treatments.

You can find out more on the video below, or on the main Caroline Foundation website here.

Professor John Crown pic courtesy of Irish Film & Television Services/herald.ie